-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q2 2024.
- Verrica Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.23M, a 44.3% increase year-over-year.
- Verrica Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $16M, a 207% increase year-over-year.
- Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.4M, a 188% increase from 2022.
- Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.99M, a 17.6% decline from 2021.
- Verrica Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.05M, a 38.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)